Evidence map›Paper›PMID 38658348›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

A Novel Risk-Adjusted Metric to Compare Hospitals on Their Antibiotic Prescribing at Hospital Discharge.

Daniel J Livorsi, James A Merchant, Hyunkeun Cho, Matthew Bidwell Goetz, Bruce Alexander, Brice Beck, Michihiko Goto

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Daniel J LivorsiCenter for Access and Delivery Research and Evaluation, Iowa City Veterans Affairs Health Care System, Iowa City, Iowa, USA.ORCID 0000-0001-8523-214X
James A MerchantDepartment of Biostatistics, University of Iowa, Iowa City, Iowa, USA.
Hyunkeun ChoDepartment of Biostatistics, University of Iowa, Iowa City, Iowa, USA.
Matthew Bidwell GoetzVA Greater Los Angeles Healthcare System, Los Angeles, California, USA.
Bruce AlexanderCenter for Access and Delivery Research and Evaluation, Iowa City Veterans Affairs Health Care System, Iowa City, Iowa, USA.
Brice BeckCenter for Access and Delivery Research and Evaluation, Iowa City Veterans Affairs Health Care System, Iowa City, Iowa, USA.
Michihiko GotoCenter for Access and Delivery Research and Evaluation, Iowa City Veterans Affairs Health Care System, Iowa City, Iowa, USA.
University of Iowa · USIowa City VA Health Care System · USUniversity of California, Los Angeles · US

Funding

Improving Empiric Antimicrobial Therapy for Gram-Negative Infections through a Personalized Smart AntibiogramK08HS027472 · AHRQ · UNIVERSITY OF IOWA · PI GOTO, MICHIHIKO · 2020 to 2024
$734k
AHRQ HHS K08 HS027472HSRD VA I01 HX003325
6 · The paper itself

Abstract

backgroundAntibiotic overuse at hospital discharge is common, but there is no metric to evaluate hospital performance at this transition of care. We built a risk-adjusted metric for comparing hospitals on their overall post-discharge antibiotic use.

methodsThis was a retrospective study across all acute-care admissions within the Veterans Health Administration during 2018-2021. For patients discharged to home, we collected data on antibiotics and relevant covariates. We built a zero-inflated, negative, binomial mixed model with 2 random intercepts for each hospital to predict post-discharge antibiotic exposure and length of therapy (LOT). Data were split into training and testing sets to evaluate model performance using absolute error. Hospital performance was determined by the predicted random intercepts.

results1 804 300 patient-admissions across 129 hospitals were included. Antibiotics were prescribed to 41.5% while hospitalized and 19.5% at discharge. Median LOT among those prescribed post-discharge antibiotics was 7 (IQR, 4-10) days. The predictive model detected post-discharge antibiotic use with fidelity, including accurate identification of any exposure (area under the precision-recall curve = 0.97) and reliable prediction of post-discharge LOT (mean absolute error = 1.48). Based on this model, 39 (30.2%) hospitals prescribed antibiotics less often than expected at discharge and used shorter LOT than expected. Twenty-eight (21.7%) hospitals prescribed antibiotics more often at discharge and used longer LOT.

conclusionsA model using electronically available data was able to predict antibiotic use prescribed at hospital discharge and showed that some hospitals were more successful in reducing antibiotic overuse at this transition of care. This metric may help hospitals identify opportunities for improved antibiotic stewardship at discharge.

Indexed as

Anti-Bacterial AgentsHospitalsPatient DischargeAgedAntimicrobial StewardshipFemaleHumansInappropriate PrescribingMaleMiddle AgedPractice Patterns, Physicians'Retrospective StudiesRisk AdjustmentUnited StatesUnited States Department of Veterans AffairsAnti-Bacterial Agentsantibiotic stewardshipcommunity-acquiredhospital dischargemetricspneumoniarisk-adjustment

Identifiers

PMID38658348
PMCPMC11426263
OpenAlexW4395109356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.